📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
India Ratings Downgrades Chemfab Alkalis to 'IND BBB+'; Outlook Negative
India Ratings and Research has downgraded Chemfab Alkalis Limited's long-term rating from 'IND A-' to 'IND BBB+' with a Negative outlook. The downgrade is driven by a 38% YoY decline in 9MFY26 EBITDA to INR 187 million and a sharp rise in net leverage to 3.6x from 1.4x in FY25. Liquidity has become severely stretched, with cash balances falling to nearly zero (INR 0.3 million) following heavy capex of INR 3,400 million since FY23. The company is struggling with low caustic soda prices and sluggish demand in its pipe business due to delays in the Jal Jeevan Mission.
Key Highlights
Long-term credit rating downgraded to 'IND BBB+' from 'IND A-' with a Negative outlook.
Net leverage (Net Debt/EBITDA) surged to 3.6x in 9MFY26 from 1.4x in FY25.
9MFY26 EBITDA fell 38% YoY to INR 187 million due to weak caustic soda realizations.
Cash and liquid investments plummeted to INR 0.3 million from INR 210 million in FY25.
Interest coverage ratio deteriorated to 3.4x in 9MFY26 from 8.9x in FY25.
💼 Action for Investors
Investors should remain cautious as the rating downgrade and negative outlook signal heightened financial risk and liquidity pressure. Key monitorables include the recovery of caustic soda prices and the successful ramp-up of the new OPVC pipe capacity to improve cash flows.
Chemfab Alkalis Reports Q3 Net Loss of ₹1.04 Cr as Revenue Drops 22% YoY
Chemfab Alkalis Limited reported a weak performance for the quarter ended December 31, 2025, swinging to a standalone net loss of ₹1.04 crore from a profit of ₹4.02 crore in the previous year's corresponding quarter. Total revenue from operations declined by 21.9% YoY to ₹61.85 crore, primarily due to a significant 57.5% slump in the PVC-O Pipes segment. While the Chemicals segment saw a marginal revenue growth of 6.2%, it continued to operate at a segment loss of ₹1.94 crore. The company's profitability was further pressured by rising finance costs and a sharp decline in segment results from the piping division.
Key Highlights
Standalone Revenue from Operations fell 21.9% YoY to ₹61.85 crore from ₹79.21 crore.
Reported a Standalone Net Loss of ₹1.04 crore compared to a Net Profit of ₹4.02 crore in Q3 FY25.
PVC-O Pipes segment revenue plummeted to ₹14.65 crore from ₹34.46 crore in the same quarter last year.
Chemicals segment revenue stood at ₹47.52 crore, showing a slight recovery from ₹44.75 crore YoY.
Finance costs increased by 21.3% YoY to ₹1.97 crore, impacting the bottom line.
💼 Action for Investors
Investors should exercise caution as the company has turned loss-making due to a severe downturn in the PVC-O Pipes segment. It is advisable to wait for signs of margin recovery in the Chemicals business and stabilization in the piping division before considering new positions.
Chemfab Alkalis Q3 FY26: Revenue Drops 21% YoY to ₹62.17 Cr; Reports PBT Loss of ₹1.38 Cr
Chemfab Alkalis reported a weak Q3 FY26 performance with consolidated revenue declining 21.5% YoY to ₹62.17 Cr and a PBT loss of ₹1.38 Cr compared to a profit of ₹5.76 Cr in the previous year. The Chlor Alkali segment faced soft global pricing, though ECU realisations showed sequential improvement to ₹38,500 per MT. The OPVC segment was significantly impacted by funding delays in the Jal Jeevan Mission, leading to a 57.5% YoY revenue drop in that division. Management remains optimistic about a recovery in Q4 FY26 following the completion of a technology modernization program and the expected start of captive hybrid power supply.
Key Highlights
Consolidated EBITDA slumped 64.32% YoY to ₹5.17 Cr with margins contracting to 8.32% from 18.29% YoY.
Chlor Alkali segment revenue grew 6.19% YoY to ₹47.52 Cr, but EBITDA margin remained low at 3.72%.
OPVC segment revenue fell sharply by 57.49% YoY to ₹14.65 Cr due to slow fund flows in government infrastructure projects.
Technology Modernisation Programme successfully completed with the new plant commissioned on December 30, 2025.
Captive Hybrid Power Plant is awaiting final clearances and is expected to drive cost savings starting Q4 FY26.
💼 Action for Investors
Investors should watch for the operational stabilization of the newly modernized plant and the impact of hybrid power on margins in the next quarter. While current results are poor, the sequential improvement in ECU realisations and non-JJM business growth in OPVC suggest a potential bottoming out.
Chemfab Alkalis Reports Q3 FY26 Net Loss of ₹1.04 Cr as Revenue Declines 22% YoY
Chemfab Alkalis reported a weak performance for Q3 FY26, swinging to a standalone net loss of ₹103.80 lakhs compared to a profit of ₹401.76 lakhs in the same quarter last year. Revenue from operations fell significantly to ₹6,185.38 lakhs, down 21.9% year-on-year, primarily due to lower contributions from the PVC-O Pipes segment. The Chemicals segment also struggled, reporting a loss at the EBIT level of ₹193.60 lakhs. Despite the downturn, the company expanded its corporate structure by incorporating a new subsidiary, Chemfab Hiitech Piping Limited, in October 2025.
Key Highlights
Revenue from operations dropped 21.9% YoY to ₹6,185.38 lakhs from ₹7,920.54 lakhs.
Reported a standalone net loss of ₹103.80 lakhs against a profit of ₹401.76 lakhs in Q3 FY25.
PVC-O Pipes segment revenue saw a sharp decline to ₹1,464.95 lakhs from ₹3,446.02 lakhs YoY.
Chemicals segment recorded a loss of ₹193.60 lakhs at the segment result level.
Incorporated a new subsidiary, Chemfab Hiitech Piping Limited, on October 28, 2025.
💼 Action for Investors
Investors should be cautious as the company has turned loss-making this quarter with significant pressure on both top-line and margins. Monitor the recovery in the PVC-O Pipes segment and the performance of the newly formed subsidiary for signs of a turnaround.
Chemfab Alkalis Commissions New INEOS Electrolyser with Rs 57 Cr Investment
Chemfab Alkalis has successfully commissioned a latest-generation INEOS Electrolyser, replacing its 30-year-old 2nd-Generation UHDE unit. The project involved a capital expenditure of approximately Rs 57 crores, which was entirely funded through internal accruals. While the production capacity remains unchanged at 180 tonnes per day, the upgrade is designed to significantly improve operational efficiency and reliability. The company expects to realize power savings and cost optimization starting from Q4 of the Financial Year 2025-26.
Key Highlights
Replacement of 30-year-old legacy equipment with latest generation INEOS Electrolyser
Total project investment of approximately Rs 57 crores funded via internal accruals
Maintains existing consent capacity of 180 tonnes per day with enhanced reliability
Anticipated power savings and cost optimization starting from Q4 FY 2025-26
💼 Action for Investors
Investors should monitor the company's operating margins in the coming quarters to verify the impact of expected power savings. The funding of this modernization through internal accruals reflects a strong cash position and disciplined capital allocation.